Dr. Anne Chandri deepika Silva-benedict MD

Media Releases

Dr. Silva-Benedict is an internist and hematology-oncologist who is currently serving patients at St. Luke’s Hospital, located in Duluth, Minnesota. Day and night, St. Luke’s care team is prepared for a full range of medical emergencies - from critical injuries to life-threatening illnesses. The extended team includes first responders, paramedics, firefighters, law enforcement, and emergency medical professionals. At remote locations and during transport, these individuals perform life-saving interventions with courage and dedication.

Dr. Silva-Benedict received her medical degree from the Virginia Commonwealth University School of Medicine in Richmond, Virginia. She went on to complete her residency in internal medicine at the Johns Hopkins University in Baltimore, Maryland; followed by her fellowship training in hematology and oncology at the Fred Hutchinson Cancer Center at the University of Washington in Seattle, Washington.

Dr. Silva-Benedict has been heavily involved in cancer research throughout her career. She has proven instrumental in helping to bring vital clinical trials to St. Luke’s through its partnership with the Whiteside Institute for Clinical Research.

Dr. Silva-Benedict has given numerous breast cancer talks throughout the community. She gave her first lecture, “Chemotherapy’s Impact: How It Affects Your Body and Mind” in St. Luke’s Understanding Cancer Survivorship: Lecture Series.

Dr. Silva-Benedict is board-certified in hematology, medical oncology, and internal medicine by the American Board of Internal Medicine (ABIM). The ABIM is a physician-led, non-profit, independent evaluation organization driven by doctors who want to achieve higher standards for better care in a rapidly changing world.

Internal medicine or general medicine is the medical specialty dealing with the prevention, diagnosis, and treatment of adult diseases. Physicians specializing in internal medicine are called internists. Hematology, also spelled haematology, is the branch of medicine concerned with the study of the cause, prognosis, treatment, and prevention of diseases related to blood; whereas oncology is a branch of medicine that deals with the prevention, diagnosis, and treatment of cancer. A hematologist-oncologist, like Dr. Silva-Benedict, is a physician who specializes in the diagnosis, treatment and/or prevention of blood diseases and cancers such as iron-deficiency anemia, hemophilia, sickle-cell disease, leukemia and lymphoma.

Recommended Articles

• Exercise Proven to Help Lymphoma Patients

  People always say that exercise is the best medicine. It's been proven through many years of research that regular exercise is really important to maintain a healthy body and mind. Doctors are always reminding their patients of the benefits of physical exercise and the power it holds to fight...

• Inspirational Blood Cancer Survivors

  Different forms of blood cancer are responsible for claiming the third most lives out of all the types of cancer. Additionally, there are currently no known preventative treatments for blood cancers, and the disease also impacts children and young people more than any other form of cancer.When it...

• How to Show Social Support for Lymphoma

  A cancer diagnosis can shake an individual’s world, and not just the physical aspects of their world, but all corners of it. Although cancer attacks the body, it necessarily also affects a person’s mental and emotional state, and it can have an impact on other people close to the affected...

• John Quinones Teams Up With Survivors For Leukemia and Lymphoma Society

  Many cancer patients suffer in silence, with the public being largely unaware of the different types of cancer and how they affect patients. Most people obviously know that cancer is well, a bad thing, but there is a lot of nuance and important information that is lost on the common citizen. Most...

• Breaking News on the Treatment of Follicular Lymphoma

  Reuters, the international news agency out of London, has announced that the FDA has given a new drug “accelerated approval,” for the treatment of follicular lymphoma.The drug, Aliqopa (copanlisib), showed complete or partial shrinkage of tumors in 59% of study participants during drug studies,...

• The Link Between Melatonin and Lymphoma

  There’s always room for improvement when it comes to the experience and outcomes of cancer treatment. Fortunately, scientists are constantly researching new, better ways to do so. Although standard treatment remains mostly the same for now, the medical community is making great strides in...